Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Tamura

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2024
Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter StudyAkira Yamamoto, Takao Hiraki, Osamu Ikeda, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 13, 2021
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)Heita Kitajima, Yoshitaka Tamura, Hiroko Yoshida, et al.
Internal Medicine (Tokyo, Japan)|September 23, 2020
Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity PneumonitisShingo Nasu, Kunimitsu Kawahara, Yuki Han, et al.
Anticancer Research|May 6, 2020
Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint InhibitorsTomohiro Kanai, Hidekazu Suzuki, Hiroko Yoshida, et al.
BMC Cancer|October 14, 2018
Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective studyTomonori Hirashima, Yoshitaka Tamura, Yuki Han, et al.
BMC Cancer|October 19, 2014
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective studyTomonori Hirashima, Takayuki Nagai, Hironori Shigeoka, et al.
Anticancer Research|November 10, 2019
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsTomonori Hirashima, Tomohiro Kanai, Hidekazu Suzuki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 14, 2020
Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center studyTomonori Hirashima, Tsuyoshi Arai, Heita Kitajima, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 30, 2018
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agentsSo Takata, Genju Koh, Yuki Han, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 4, 2023
Hepatic venous outflow obstruction after adult living donor liver transplantationYuzuru Sambommatsu, Kazuya Hirukawa, Keita Shimata, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2024
Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter StudyAkira Yamamoto, Takao Hiraki, Osamu Ikeda, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 13, 2021
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)Heita Kitajima, Yoshitaka Tamura, Hiroko Yoshida, et al.
Internal Medicine (Tokyo, Japan)|September 23, 2020
Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity PneumonitisShingo Nasu, Kunimitsu Kawahara, Yuki Han, et al.
Anticancer Research|May 6, 2020
Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint InhibitorsTomohiro Kanai, Hidekazu Suzuki, Hiroko Yoshida, et al.
BMC Cancer|October 14, 2018
Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective studyTomonori Hirashima, Yoshitaka Tamura, Yuki Han, et al.
BMC Cancer|October 19, 2014
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective studyTomonori Hirashima, Takayuki Nagai, Hironori Shigeoka, et al.
Anticancer Research|November 10, 2019
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsTomonori Hirashima, Tomohiro Kanai, Hidekazu Suzuki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 14, 2020
Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center studyTomonori Hirashima, Tsuyoshi Arai, Heita Kitajima, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 30, 2018
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agentsSo Takata, Genju Koh, Yuki Han, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 4, 2023
Hepatic venous outflow obstruction after adult living donor liver transplantationYuzuru Sambommatsu, Kazuya Hirukawa, Keita Shimata, et al.
Pageof 9